CareRx Corporation (CHHHF)
USD 1.28
(0.0%)
USD 1.28
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -5.4 Million CAD | 84.27% |
| 2022 | -34.35 Million CAD | -51.14% |
| 2021 | -22.73 Million CAD | -25.01% |
| 2020 | -18.18 Million CAD | 60.19% |
| 2019 | -45.67 Million CAD | -46.9% |
| 2018 | -31.09 Million CAD | -1464.33% |
| 2017 | 2.27 Million CAD | 111.58% |
| 2016 | -19.67 Million CAD | -142.7% |
| 2015 | 46.08 Million CAD | 180.22% |
| 2014 | -57.44 Million CAD | 36.93% |
| 2013 | -91.09 Million CAD | -1155.04% |
| 2012 | -7.25 Million CAD | 19.19% |
| 2011 | -8.98 Million CAD | -307.53% |
| 2010 | 4.32 Million CAD | 163.9% |
| 2009 | 1.64 Million CAD | 72.27% |
| 2008 | 952 Thousand CAD | 26.15% |
| 2007 | 754.68 Thousand CAD | 1425.6% |
| 2006 | 49.46 Thousand CAD | 114.21% |
| 2005 | -348.08 Thousand CAD | -366.51% |
| 2004 | 130.61 Thousand CAD | -73.28% |
| 2003 | 488.73 Thousand CAD | 927.29% |
| 2002 | -59.07 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -1.37 Million CAD | -166.73% |
| 2024 Q1 | -517 Thousand CAD | 86.03% |
| 2023 Q3 | -1.43 Million CAD | -176.4% |
| 2023 Q1 | -2.49 Million CAD | 46.73% |
| 2023 Q4 | -3.7 Million CAD | -157.48% |
| 2023 FY | -5.4 Million CAD | 84.27% |
| 2023 Q2 | 1.88 Million CAD | 175.45% |
| 2022 Q2 | -25.12 Million CAD | -809.81% |
| 2022 Q3 | -1.78 Million CAD | 92.91% |
| 2022 Q4 | -4.68 Million CAD | -162.63% |
| 2022 FY | -34.35 Million CAD | -51.14% |
| 2022 Q1 | -2.76 Million CAD | 63.12% |
| 2021 Q4 | -7.48 Million CAD | -90.66% |
| 2021 Q3 | -3.92 Million CAD | 53.73% |
| 2021 Q2 | -8.48 Million CAD | -44.72% |
| 2021 Q1 | -5.86 Million CAD | -94.17% |
| 2021 FY | -22.73 Million CAD | -25.01% |
| 2020 Q2 | -14.14 Million CAD | -366.24% |
| 2020 Q1 | 5.31 Million CAD | 128.06% |
| 2020 FY | -18.18 Million CAD | 60.19% |
| 2020 Q3 | -6.4 Million CAD | 54.71% |
| 2020 Q4 | -3.02 Million CAD | 52.85% |
| 2019 Q2 | -1.64 Million CAD | 68.85% |
| 2019 Q1 | -5.29 Million CAD | 30.13% |
| 2019 FY | -45.67 Million CAD | -46.9% |
| 2019 Q4 | -18.93 Million CAD | -440.96% |
| 2019 Q3 | -3.5 Million CAD | -112.31% |
| 2018 Q2 | -20.58 Million CAD | -1093.91% |
| 2018 Q4 | -7.57 Million CAD | -742.83% |
| 2018 FY | -31.09 Million CAD | -1464.33% |
| 2018 Q1 | -1.72 Million CAD | -156.25% |
| 2018 Q3 | -899 Thousand CAD | 95.63% |
| 2017 Q1 | -3.36 Million CAD | -107.26% |
| 2017 FY | 2.27 Million CAD | 111.58% |
| 2017 Q4 | 3.06 Million CAD | 1671.68% |
| 2017 Q3 | 173 Thousand CAD | -93.13% |
| 2017 Q2 | 2.51 Million CAD | 174.73% |
| 2016 Q1 | -9.95 Million CAD | -114.14% |
| 2016 Q2 | -11.42 Million CAD | -14.78% |
| 2016 FY | -19.67 Million CAD | -142.7% |
| 2016 Q3 | 3.32 Million CAD | 129.11% |
| 2016 Q4 | -1.62 Million CAD | -148.87% |
| 2015 FY | 46.08 Million CAD | 180.22% |
| 2015 Q1 | -12.35 Million CAD | -53.57% |
| 2015 Q4 | 70.39 Million CAD | 1508.12% |
| 2015 Q3 | -4.99 Million CAD | 28.16% |
| 2015 Q2 | -6.95 Million CAD | 43.65% |
| 2014 Q3 | 763 Thousand CAD | 103.46% |
| 2014 FY | -57.44 Million CAD | 36.93% |
| 2014 Q1 | -28.09 Million CAD | 35.55% |
| 2014 Q4 | -8.04 Million CAD | -1154.0% |
| 2014 Q2 | -22.07 Million CAD | 21.43% |
| 2013 FY | -91.09 Million CAD | -1155.04% |
| 2013 Q3 | -39.27 Million CAD | -216.14% |
| 2013 Q2 | -12.42 Million CAD | -395.86% |
| 2013 Q1 | 4.19 Million CAD | 110.91% |
| 2013 Q4 | -43.59 Million CAD | -11.0% |
| 2012 Q4 | -38.49 Million CAD | -506.05% |
| 2012 Q2 | 42.32 Million CAD | 993.71% |
| 2012 Q1 | -4.73 Million CAD | 92.98% |
| 2012 Q3 | -6.35 Million CAD | -115.01% |
| 2012 FY | -7.25 Million CAD | 19.19% |
| 2011 Q4 | -67.48 Million CAD | -228.24% |
| 2011 Q2 | 11.72 Million CAD | 265.71% |
| 2011 Q3 | 52.62 Million CAD | 348.94% |
| 2011 Q1 | -7.07 Million CAD | -1137.24% |
| 2011 FY | -8.98 Million CAD | -307.53% |
| 2010 Q1 | 865 Thousand CAD | 923.81% |
| 2010 FY | 4.32 Million CAD | 163.9% |
| 2010 Q2 | 1.03 Million CAD | 19.88% |
| 2010 Q4 | 682 Thousand CAD | -48.57% |
| 2010 Q3 | 1.32 Million CAD | 27.87% |
| 2009 Q3 | 888 Thousand CAD | 71.43% |
| 2009 Q1 | 339 Thousand CAD | 28.48% |
| 2009 Q2 | 518 Thousand CAD | 52.8% |
| 2009 FY | 1.64 Million CAD | 72.27% |
| 2009 Q4 | -105 Thousand CAD | -111.82% |
| 2008 Q3 | 225.16 Thousand CAD | -13.01% |
| 2008 Q4 | 263.85 Thousand CAD | 17.18% |
| 2008 FY | 952 Thousand CAD | 26.15% |
| 2008 Q1 | 204.33 Thousand CAD | -7.19% |
| 2008 Q2 | 258.84 Thousand CAD | 26.68% |
| 2007 Q3 | 98.72 Thousand CAD | -60.45% |
| 2007 Q2 | 249.6 Thousand CAD | -5.68% |
| 2007 Q1 | 264.64 Thousand CAD | 182.76% |
| 2007 FY | 754.68 Thousand CAD | 1425.6% |
| 2007 Q4 | 220.16 Thousand CAD | 123.0% |
| 2006 Q1 | 150.8 Thousand CAD | 714.61% |
| 2006 FY | 49.46 Thousand CAD | 114.21% |
| 2006 Q2 | 165.27 Thousand CAD | 9.6% |
| 2006 Q4 | -319.77 Thousand CAD | -701.51% |
| 2006 Q3 | 53.16 Thousand CAD | -67.84% |
| 2005 Q3 | 42.7 Thousand CAD | 114.37% |
| 2005 Q1 | -112.06 Thousand CAD | -12.41% |
| 2005 FY | -348.08 Thousand CAD | -366.51% |
| 2005 Q2 | -297.23 Thousand CAD | -165.24% |
| 2005 Q4 | 18.51 Thousand CAD | -56.65% |
| 2004 Q2 | 112.95 Thousand CAD | -58.06% |
| 2004 FY | 130.61 Thousand CAD | -73.28% |
| 2004 Q4 | -99.69 Thousand CAD | 34.23% |
| 2004 Q3 | -151.58 Thousand CAD | -234.2% |
| 2004 Q1 | 269.29 Thousand CAD | 464.39% |
| 2003 Q2 | 238.15 Thousand CAD | 631.38% |
| 2003 Q1 | -44.81 Thousand CAD | -223.85% |
| 2003 FY | 488.73 Thousand CAD | 927.29% |
| 2003 Q4 | 47.71 Thousand CAD | -54.41% |
| 2003 Q3 | 104.65 Thousand CAD | -56.06% |
| 2002 Q4 | -13.83 Thousand CAD | 59.35% |
| 2002 Q3 | -34.04 Thousand CAD | -204.09% |
| 2002 FY | -59.07 Thousand CAD | 0.0% |
| 2002 Q2 | -11.19 Thousand CAD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.73 Million USD | 49.651% |
| Arem Pacific Corporation | -53.66 Thousand USD | -9971.554% |
| Assisted 4 Living, Inc. | -118.27 Thousand USD | -4469.936% |
| BioCorRx Inc. | -3.76 Million USD | -43.486% |
| Bionik Laboratories Corp. | -4.94 Million USD | -9.28% |
| Banyan Corp. | -5.48 Million USD | 1.423% |
| Clearday, Inc. | -14.3 Million USD | 62.224% |
| Dental Patient Care America, Inc. | 8974.00 USD | 60329.552% |
| Quantum Medical Transport, Inc. | 222.84 USD | 2425607.09% |
| Empower Clinics Inc. | -2826.87 USD | -191100.869% |
| First Choice Healthcare Solutions, Inc. | -8.17 Million USD | 33.853% |
| Selectis Health, Inc. | -3.97 Million USD | -36.112% |
| Ethema Health Corporation | 1.17 Million USD | 559.375% |
| HealthLynked Corp. | -1.01 Million USD | -433.984% |
| HQDA Elderly Life Network Corp. | - USD | Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.78 Million USD | -93.855% |
| JRSIS Health Care Corporation | -80.91 Thousand USD | -6580.097% |
| Comjoyful International Company | -20.62 Thousand USD | -26104.79% |
| Medical Facilities Corporation | 18.5 Million USD | 129.211% |
| MedSmart Group Inc. | -76.23 Thousand USD | -6989.547% |
| North America Frac Sand, Inc. | -798.47 Thousand USD | -576.914% |
| Nova Leap Health Corp. | -1.05 Million USD | -412.477% |
| Nexteligent Holdings, Inc. | -295.32 Thousand USD | -1730.181% |
| PAO Group, Inc. | 235.5 Thousand USD | 2395.039% |
| Primemd Inc. | 3.14 Million USD | 272.122% |
| Raffles Medical Group Ltd | 68.31 Million USD | 107.912% |
| Ryman Healthcare Limited | 2.85 Million USD | 289.382% |
| Stem Cell Authority, Ltd. | -4233.00 USD | -127587.219% |
| SETO Holdings, Inc. | - USD | Infinity% |
| Optima Medical Innovations Corp. | -3.96 Million USD | -36.453% |
| Mycotopia Therapies, Inc. | -1.18 Million USD | -357.529% |
| U.S. NeuroSurgical Holdings, Inc. | -816 Thousand USD | -562.377% |
| Veltex Corporation | -1.06 Million USD | -408.436% |
| World Financial Holding Group | -28.42 Thousand USD | -18914.283% |
| Xcelerate Inc. | -2.75 Million USD | -96.495% |